Press Releases | Microbix Biosystems Inc.
50646
page-template,page-template-blog-standard,page-template-blog-standard-php,page,page-id-50646,page-child,parent-pageid-1298,edgt-core-1.0,,vigor-ver-1.12, vertical_menu_with_scroll,side_menu_slide_with_content,width_370,wpb-js-composer js-comp-ver-5.2,vc_responsive

Press Releases

Microbix Announces Annual Meeting Voting Results

TORONTO March 30, 2017 — Microbix Biosystems Inc. (TSX: MBX) (“Microbix” or the “Company”), an innovator of biological products and technologies, announces the results of the Annual Meeting of Shareholders which was held on March 29, 2017, at which 37.07% of the issued and outstanding...

Read More

Microbix Reports Significant Revenue Growth in First Quarter

Company Records Non-Cash Debt Restructuring Expense to Refinance Debentures and Fund Continued Growth Initiatives TORONTO, February 14, 2017 - Microbix Biosystems Inc. (TSX: MBX) (“Microbix” or the “Company”), an innovator of biological products and technologies, today reported financial results for its fiscal first quarter ended December...

Read More

Microbix Appoints Meridian Life Science as Distributor in Asia Pacific – Meridian an Exclusive Distributor in China, Hong Kong, Taiwan and Macau

TORONTO, January 12, 2017 - Microbix Biosystems Inc. (TSX: MBX) (“Microbix”), an innovator of biological products and technologies, today announced it has signed a distribution agreement (the “Agreement”) with Meridian Life Science, Inc. (“Meridian”) a wholly owned company of Meridian Bioscience, Inc. (NASDAQ: VIVO) a...

Read More